CALITHERA BIOSCIENCES, INC. FORM OF LONG-TERM COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • March 31st, 2022 • Calithera Biosciences, Inc. • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five-year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Calithera Biosciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered h
CALITHERA BIOSCIENCES, INC. and AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC as Warrant Agent Warrant Agency Agreement Dated as of , 2022Warrant Agency Agreement • March 31st, 2022 • Calithera Biosciences, Inc. • Pharmaceutical preparations • New York
WARRANT AGENCY AGREEMENT, dated as of , 2022 (“Agreement”), between Calithera Biosciences, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company (the “Warrant Agent”).
Calithera Biosciences, Inc. 18,518,519 Shares of Common Stock Short-Term Common Warrants to Purchase 18,518,519 Shares of Common Stock Long-Term Common Warrants to Purchase 18,518,519 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • March 31st, 2022 • Calithera Biosciences, Inc. • Pharmaceutical preparations • New York
